Short Interest in Jounce Therapeutics, Inc. (NASDAQ:JNCE) Drops By 22.5%

Retrieved on: 2021-02-16 10:18:45

Tags for this article:

Click the tags to see associated articles and topics

Short Interest in Jounce Therapeutics, Inc. (NASDAQ:JNCE) Drops By 22.5%. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,546,555 shares of the company's stock worth $10,826,000 after purchasing an additional 336,420 shares during the period.

Article found on: www.marketbeat.com